Daniel Markowitz
Stock Analyst at Evercore ISI Group
(1.85)
# 3,257
Out of 4,988 analysts
9
Total ratings
57.14%
Success rate
0.45%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMBS Rambus | Maintains: Outperform | $81 → $114 | $102.35 | +11.38% | 1 | Sep 16, 2025 | |
| TMDX TransMedics Group | Initiates: Outperform | $155 | $122.29 | +26.75% | 1 | Sep 16, 2025 | |
| INSP Inspire Medical Systems | Initiates: Outperform | $150 | $79.88 | +87.78% | 1 | Sep 2, 2025 | |
| NTRA Natera | Initiates: Outperform | $170 | $181.11 | -6.13% | 1 | Jul 28, 2025 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $275 → $350 | $254.85 | +37.34% | 2 | Jul 25, 2025 | |
| RGEN Repligen | Maintains: In-Line | $140 → $130 | $122.30 | +6.30% | 2 | Jul 8, 2025 | |
| TECH Bio-Techne | Initiates: Outperform | $75 | $53.15 | +41.11% | 1 | Mar 18, 2025 |
Rambus
Sep 16, 2025
Maintains: Outperform
Price Target: $81 → $114
Current: $102.35
Upside: +11.38%
TransMedics Group
Sep 16, 2025
Initiates: Outperform
Price Target: $155
Current: $122.29
Upside: +26.75%
Inspire Medical Systems
Sep 2, 2025
Initiates: Outperform
Price Target: $150
Current: $79.88
Upside: +87.78%
Natera
Jul 28, 2025
Initiates: Outperform
Price Target: $170
Current: $181.11
Upside: -6.13%
West Pharmaceutical Services
Jul 25, 2025
Maintains: Outperform
Price Target: $275 → $350
Current: $254.85
Upside: +37.34%
Repligen
Jul 8, 2025
Maintains: In-Line
Price Target: $140 → $130
Current: $122.30
Upside: +6.30%
Bio-Techne
Mar 18, 2025
Initiates: Outperform
Price Target: $75
Current: $53.15
Upside: +41.11%